ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Potential Urine Protein Biomarkers for Kidney Transplantation Dysfunction Through Quantitative Proteomics

T. Sigdel,1 N. Salomonis,2 C. Nicora,3 J. He,3 W.-J. Qian,3 D. Camp,3 M. Sarwal.1

1UCSF, San Francisco, CA
2Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Pacific Northwest National Laboratory, Richland, WA.

Meeting: 2015 American Transplant Congress

Abstract number: B251

Keywords: Kidney transplantation, Rejection, Urinalysis

Session Information

Date: Sunday, May 3, 2015

Session Name: Poster Session B: Translational Genetics and Proteomics in Transplantation

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Related Abstracts
  • Portrait of CAD with IF-TA Development Post Kidney Transplantation. Proteomics as Noninvasive Biomarkers
  • Serum and Urine IP–10 and Fractalkine Are Effective Biomarkers for Prediction of Early Kidney Transplant Rejection

Introduction: Inability to effectively monitor transplant injuries leads to immune and non-immune mediated graft dysfunction. A non-invasive tool to monitor such injuries is an unmet need.

Method:Quantitative analysis of the urinary proteome was performed using iTRAQ based LC-MS, on a set of 264 biobanked urine samples with matched biopsies that included 70 acute rejection (AR); 70 stable graft (STA); 70 transplant glomerulopathy (TG), 35 BK virus nephropathy (BKVN); 10 patients with nephrotic syndrome (NS), and 9 normal healthy controls (HC). Potential biomarker proteins from the initial discovery were analyzed for validation by mass spectrometry (MS) based selected reaction monitoring method (SRM) on two set of independent cohorts of 71 (20 AR, 20 STA, 15 TG, 16 BKVN ) biopsy matched urine samples. The respective peptides were synthesized with heavy label and mass spectrometry data was transformed and normalized against urine creatinine.

Result: We were able to successfully optimize and detect urinary peptides from 67 proteins including 36 AR-specific, 8 BKVN specific and 23 TG specific. From the first validation set of 20 AR, 20 STA, 15 TG, 16 BKVN we have validated significant increase of 16 AR-specific, 12 TG-specific and 6 BK specific proteins with a criteria of p<0.01. In the first phase, we selected four proteins for ELISA validation, FGB, FGG, SUMO2, and HLA-DRB1 based on their relevance in AR. Urinary FBB in AR was significantly higher vs STA (p=0.04), vs CAI (p=0.05), and vs BKV (p=0.03). The increased urine protein level of FBG in AR (p=0.04), vs CAI (p=0.05), and vs BKV (p=0.02). The urine protein level of HLA-DRB1 was significantly higher in AR vs STA (p=0.001), vs CAI) (p=0.003), and vs BKV (p=0.04). Urine SUMO2 level was significantly higher in AR vs STA urine (p=0.005), and vs BKVN urine (p=0.04). An ROC analysis to identify AR from the rest of the phenotypes (CAI, BK, and STA) on the data from three urine proteins (FBB, FGG, and HLA-DRB1) yielded an AUC of 0.8.

Conclusion: We have demonstrated that mass spectrometry based proteomic discovery can identify potential biomarkers further validation of these in a larger sample set of a clinical trial is underway which will further validate and facilitate in developing a non-invasive diagnostic tool for transplant injury surveillance.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Sigdel T, Salomonis N, Nicora C, He J, Qian W-J, Camp D, Sarwal M. Potential Urine Protein Biomarkers for Kidney Transplantation Dysfunction Through Quantitative Proteomics [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/potential-urine-protein-biomarkers-for-kidney-transplantation-dysfunction-through-quantitative-proteomics/. Accessed April 15, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.